"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
11,"no","yes","High body mass index and cancer risk—a Mendelian randomisation study",2016,"European Journal of Epidemiology","10.1007/s10654-016-0147-5","Benn","Marianne Benn","marianne.benn@regionh.dk","Department of Clinical Biochemistry, Gentofte Hospital, Copenhagen University Hospital, Kildega ̊rdsvej 28, 2900 Gentofte, Denmark","Effect of body mass index on cancer","High body mass index (BMI) has been associ- ated with increased risk of some cancer. Whether these reflect causal associations is unknown. We examined this issue.","One-sample","colon cancer","colon cancer","cancer","colon cancer (ICD-7:153; ICD-10:C18)","Current study","20+","both","1499","97458",NA,NA,NA,"Healthy","European","BMI","BMI","Current study","20+","both","98957","Manually fill",NA,"Healthy","European ancestry",NA,"Not discussed","Not discussed","Confounder analysis","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"5",NA,NA,"yes","Power to exclude a causal risk of cancer (odds ratio) at a two-sided a of 0.05 and b of 80 % was calculated using an online power calculation tool (https://sb452.shi nyapps.io/power/) for instrumental variable analysis in Mendelian Randomization studies with binary outcomes","Two-stage-least-squares",NA,NA,NA,NA,NA,"None performed","F statistic > 10","STATA","ivreg2 and ivpois","Not discussed","Not discussed","Not discussed","10 kg/m2","case/control","Hazard ratio","1.75",NA,"95","0.47","6.58","0.41",NA,NA,NA,"To minimize influence from pleiotropy, we carefully selected genetic instruments and used genetic variants located in five different genes combined in an allele score for body mass index, making it unlikely that the genetic variants in the allele score have the same pleiotropic effects","Not discussed","Lack of power for rare cancer",NA,62
142,"no","yes","Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk",2015,"Cancer epidemiology biomarkers and prevention","10.1158/1055-9965.EPI-14-1310","Thrift","Aaron P. Thrift","aaron.thrift@bcm.edu","Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498","Effect of body mass index on colon, rectal, and colorectal cancer","As risk estimates from observational studies may be biased and/or confounded, we conducted a Mendelian randomization study to estimate the causal association between BMI and colorectal cancer.","One-sample","colon cancer","colon cancer","cancer","Diagnosed by doctor","Current study","Not discussed","both","10286","6864",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","Not discussed","both","17150","322154","one-sample","Healthy","European","First 3 prinicipal components","Not discussed","Not discussed","Looked at association of GRS with potential confounders","5x10-8","Not discussed","Not discussed","P ≥ 1 × 10−4",NA,NA,"77","77",NA,"Not discussed",NA,"two-stage control function instrumental variable approach",NA,NA,NA,NA,NA,"All individuals","F-statistic","Stata","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","Case/control","OR","1.5",NA,"95","1.08","2.07","Not discussed","None",NA,"A final limitation in this study is the lack of data on tumor molecular phenotype","we feel that it is highly unlikely that a large subset of the 77 SNPs in the score would have pleiotropic associations with BMI and colorectal cancer. If the IV is associated with colorectal cancer risk through the same metabolic pathways (e.g., inflammation, oxidative stress, glucose/insulin dysregulation) that are suspected to connect BMI to carcinogenesis, then this second assumption would still hold, as both the IV and BMI would be considered markers of altered metabolic (or related) risk factors.","Not discussed","our IV analyses may have been underpowered as the IV explained less than 2% of total phenotypic variation for BMI",NA,1688
142,"no","yes","Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk",2015,"Cancer epidemiology biomarkers and prevention","10.1158/1055-9965.EPI-14-1313","Thrift","Aaron P. Thrift","aaron.thrift@bcm.edu","Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498","Effect of body mass index on colon, rectal, and colorectal cancer","As risk estimates from observational studies may be biased and/or confounded, we conducted a Mendelian randomization study to estimate the causal association between BMI and colorectal cancer.","One-sample","colon cancer","colon cancer","cancer","Diagnosed by doctor","Current study","Not discussed","male","4539","2942",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","Not discussed","male","7481","322154","one-sample","Healthy","European","First 3 prinicipal components","Not discussed","Not discussed","Looked at association of GRS with potential confounders","5x10-8","Not discussed","Not discussed","P ≥ 1 × 10−4",NA,NA,"77","77",NA,"Not discussed",NA,"two-stage control function instrumental variable approach",NA,NA,NA,NA,NA,"Males only","F-statistic","Stata","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","Case/control","OR","1.03",NA,"95","0.6","1.78","Not discussed","None",NA,"A final limitation in this study is the lack of data on tumor molecular phenotype","we feel that it is highly unlikely that a large subset of the 77 SNPs in the score would have pleiotropic associations with BMI and colorectal cancer. If the IV is associated with colorectal cancer risk through the same metabolic pathways (e.g., inflammation, oxidative stress, glucose/insulin dysregulation) that are suspected to connect BMI to carcinogenesis, then this second assumption would still hold, as both the IV and BMI would be considered markers of altered metabolic (or related) risk factors.","Not discussed","our IV analyses may have been underpowered as the IV explained less than 2% of total phenotypic variation for BMI",NA,1691
142,"no","yes","Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk",2015,"Cancer epidemiology biomarkers and prevention","10.1158/1055-9965.EPI-14-1316","Thrift","Aaron P. Thrift","aaron.thrift@bcm.edu","Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498","Effect of body mass index on colon, rectal, and colorectal cancer","As risk estimates from observational studies may be biased and/or confounded, we conducted a Mendelian randomization study to estimate the causal association between BMI and colorectal cancer.","One-sample","colon cancer","colon cancer","cancer","Diagnosed by doctor","Current study","Not discussed","female","5747","3922",NA,NA,NA,"Case/control","European","BMI","BMI","Locke 2015 BMI European adults both","Not discussed","female","9669","322154","one-sample","Healthy","European","First 3 prinicipal components","Not discussed","Not discussed","Looked at association of GRS with potential confounders","5x10-8","Not discussed","Not discussed","P ≥ 1 × 10−4",NA,NA,"77","77",NA,"Not discussed",NA,"two-stage control function instrumental variable approach",NA,NA,NA,NA,NA,"Females only","F-statistic","Stata","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","Case/control","OR","1.94",NA,"95","1.3","2.91","Not discussed","None",NA,"A final limitation in this study is the lack of data on tumor molecular phenotype","we feel that it is highly unlikely that a large subset of the 77 SNPs in the score would have pleiotropic associations with BMI and colorectal cancer. If the IV is associated with colorectal cancer risk through the same metabolic pathways (e.g., inflammation, oxidative stress, glucose/insulin dysregulation) that are suspected to connect BMI to carcinogenesis, then this second assumption would still hold, as both the IV and BMI would be considered markers of altered metabolic (or related) risk factors.","Not discussed","our IV analyses may have been underpowered as the IV explained less than 2% of total phenotypic variation for BMI",NA,1694
